Insights from nanomedicine into chloroquine efficacy against COVID-19 Chloroquine -an approved malaria drug -is known in nanomedicine research for the investigation of nanoparticle uptake in cells, and may have potential for the treatment of COVID-19.
Competing interests The authors declare no competing interests.
References
Dowall, None, J. Gen. Virol
Gentile, None, Future Oncol
Haladyj, Sikora, Felis-Giemza, Olesinska, None, M. Reumatologia
Hempelmann, None, E. Parasitol. Res
Inoue, None, J. Virol
Keyaerts, None, Antimicrob. Agents Chemother
Li, None, Nature
Liu, None, Cell Discov
Madrid, None, PLoS One
Miller, None, Dev. Cell
Pelt, None, Pharmacol. Ther
Roques, None, Viruses
Savarino, Boelaert, Cassone, Majori, Cauda, None, Lancet Infect. Dis
Vincent, None, Virol. J
Wang, None, Cell Res
Wang, None, Cell Res
Wolfram, Ferrari, None, Nano Today
Wolfram, None, Sci Rep
Wrapp, None, Science
Wu, Li, Peng, Li, Proc. Natl Acad. Sci
Zhu, None, N. Engl. J. Med
